moxifloxacin has been researched along with thiazoles in 8 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (thiazoles) | Trials (thiazoles) | Recent Studies (post-2010) (thiazoles) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 33,179 | 2,100 | 12,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Asbell, PA; Epstein, SP; Sosa, AB | 1 |
| Leggio, M; Podos, SD; Pucci, MJ; Thanassi, JA | 1 |
| de Koning, P; Goldwater, R; Kaibara, A; Keirns, JJ; Kowalski, DL; Lee, JH; Malik, M; Moy, SS; Mujais, SK; Schaddelee, MP; van Gelderen, EM; Yen, M | 1 |
| Brossard, P; Darpo, B; Dingemanse, J; Hoch, M; Stoltz, R; Zhou, M | 1 |
| Adelakun, A; Bhatnagar, V; Chen, Q; Emadi, A; Farshidpour, M; Holtzman, N; Kendall, T; Stevenson, B | 1 |
| Hasunuma, T; Jang, IJ; Kaneko, M; Kaniwa, N; Kawai, S; Saito, Y; Takeuchi, M; Tohkin, M; Uyama, Y; Watanabe, H; Yamazoe, Y; Yimin, C | 1 |
| Kreiswirth, BN; Kurepina, N; Meinke, PT; Olsen, DB; Singh, SB; Xu, L; Young, K | 1 |
| Bonate, PL | 1 |
3 trial(s) available for moxifloxacin and thiazoles
| Article | Year |
|---|---|
Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study.
Topics: Acetanilides; Adolescent; Adrenergic beta-Agonists; Adult; Anti-Infective Agents; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Sex Characteristics; Thiazoles; Urinary Bladder, Overactive; Young Adult | 2012 |
Effect of ponesimod, a selective S1P1 receptor modulator, on the QT interval in healthy individuals.
Topics: Action Potentials; Adolescent; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Receptors, Lysosphingolipid; Risk Assessment; Sphingosine-1-Phosphate Receptors; Thiazoles; Time Factors; Young Adult | 2015 |
Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.
Topics: Adult; Asian People; Cytochrome P-450 CYP2C9; Fluoroquinolones; Glucuronosyltransferase; Humans; Liver-Specific Organic Anion Transporter 1; Male; Meloxicam; Moxifloxacin; Polymorphism, Genetic; Simvastatin; Thiazines; Thiazoles; White People; Young Adult | 2016 |
5 other study(ies) available for moxifloxacin and thiazoles
| Article | Year |
|---|---|
Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells.
Topics: Anti-Infective Agents; Aza Compounds; Cell Line; Cell Survival; Ciprofloxacin; Conjunctiva; Drug Evaluation, Preclinical; Epithelial Cells; Epithelium, Corneal; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Tetrazolium Salts; Thiazoles | 2008 |
Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Quinolines; Quinolones; Rifampin; Staphylococcus; Thiazoles; Vancomycin | 2012 |
Diseases at the crossroads: chronic myelogenous leukemia and tuberculosis.
Topics: Adult; Antitubercular Agents; Dasatinib; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Moxifloxacin; Peritonitis, Tuberculous; Protein Kinase Inhibitors; Pyrazinamide; Pyrimidines; Thiazoles | 2015 |
Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Intercellular Signaling Peptides and Proteins; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Peptides; Peptides, Cyclic; Rifampin; Solubility; Thiazoles | 2017 |
The application of extreme value theory to pharmacometrics.
Topics: Acetanilides; Cross-Over Studies; Data Interpretation, Statistical; Datasets as Topic; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Heart Rate; Humans; Male; Minimal Clinically Important Difference; Models, Biological; Moxifloxacin; Pharmacology, Clinical; Placebos; Randomized Controlled Trials as Topic; Thiazoles | 2021 |